Ame Company For Medical Supplies

TADAWUL:9527.SR

93 (SAR) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SAR.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q2
Operating Activities:
Net Income 26.59311.31922.19711.30715.37713.7257.498
Depreciation & Amortization 0.9470.8240.7110.4780.3750.3140.145
Deferred Income Tax 0000000
Stock Based Compensation 0000000
Change In Working Capital -44.821.594-6.6629.58-27.22-10.9413.064
Accounts Receivables -24.5823.808-17.16517.798-18.093-4.81-8.249
Change In Inventory -7.214-2.8234.103-12.854-8.703-8.4375.454
Change In Accounts Payables 0.0860.5110-0.40.153-0.1330.378
Other Working Capital -13.110.0976.45.036-0.5762.445.48
Other Non Cash Items 31.3313.80117.505-8.43930.82216.4516.723
Operating Cash Flow -19.55417.38619.26616.514-8.045.54114.723
Investing Activities:
Investments In Property Plant And Equipment -0.06-0.39-1.544-0.088-0.727-0.298-0.037
Acquisitions Net 000000.0760
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites 0000000
Investing Cash Flow -0.06-0.39-1.544-0.088-0.727-0.223-0.037
Financing Activities:
Debt Repayment 00000-4.50
Common Stock Issued 0000000
Common Stock Repurchased 0000000
Dividends Paid -140-13.990-12.250-1.6
Other Financing Activities -0.750-0.634000-0
Financing Cash Flow -14.75-0.013-14.624-0.113-12.642-4.599-1.688
Other Information:
Effect Of Forex Changes On Cash 0000-000
Net Change In Cash -34.36316.9833.09816.313-21.4080.7212.997
Cash At End Of Period 9.03943.40326.41923.3217.00828.41727.697